Clinical Trials Logo

VEGF Overexpression clinical trials

View clinical trials related to VEGF Overexpression.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT03506750 Recruiting - Clinical trials for Proliferative Diabetic Retinopathy

Day Regimes of CONbercept on CytokinEs of PDR Patients Undergoing Vitrectomy - Trial (CONCEPT)

CONCEPT
Start date: June 3, 2017
Phase: Phase 4
Study type: Interventional

Patients with proliferative diabetic retinopathy requiring surgical intervention will receive a pre-operative injection of Conbercept. Patients will be recruited into different groups according to variable time intervals (1 to 7 days) between intravitreous injection and surgery. At initial, pre-injection aqueous humor and blood sample will be collected in order to provide baseline VEGF-A, -B, placental growth factor (PIGF), and other cytokine levels. At the onset of the vitrectomy, a second aqueous humor, blood, and vitreous sample will be taken to obtain intra-operative levels of , VEGF-A, -B, PIGF, and other cytokine levels.